A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus
- 25 September 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 57 (6) , 1112-1114
- https://doi.org/10.1212/wnl.57.6.1112
Abstract
Levetiracetam was recently approved as adjunctive therapy for partial onset seizures. The authors conducted an open-label trial of levetiracetam in eight patients with chronic myoclonus. Patients were assessed by using the Unified Myoclonus Rating Scale. Levetiracetam was well tolerated. Three of five patients with cortical myoclonus experienced reductions in their myoclonus scores, providing support for a larger, placebo-controlled trial in cortical myoclonus. ;•••>Keywords
This publication has 7 references indexed in Scilit:
- Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetamNeurology, 2001
- Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugsPharmacological Research, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profilesEpileptic Disorders, 2000
- Revisiting the Concept of Identifiable NeuronsBrain, Behavior and Evolution, 2000
- Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placeboJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in JapanMovement Disorders, 1996